Related Experiment Video
Updated: May 2, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Screening of the central nervous system in children with invasive pulmonary aspergillosis
Emmi Broenen1, Annelies Mavinkurve-Groothuis1, Karin Kamphuis-van Ulzen2
1Department of Pediatrics, Radboud University Nijmegen Medical Center, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.
Abstract:
The existing guidelines regarding the management of invasive pulmonary aspergillosis do not recommend screening of the extra-pulmonary sites. Due to the fact that the presence of central nervous system (CNS) aspergillosis will influence treatment decisions regarding which antifungal to use and the aimed target concentrations of azoles in plasma, to be informed about dissemination of the infection to the CNS is absolutely necessary. We demonstrate the need for a structured approach to screening of pediatric patients for CNS aspergillosis.
Insights
Current guidelines for invasive pulmonary aspergillosis neglect screening for extra-pulmonary sites. Early detection of central nervous system (CNS) aspergillosis in children is crucial for effective antifungal treatment strategies.
Area of Science:
- Mycology
- Infectious Diseases
- Pediatric Medicine
Background:
- Invasive pulmonary aspergillosis management guidelines often omit screening for extra-pulmonary infections.
- Dissemination to the central nervous system (CNS) significantly impacts treatment choices and therapeutic drug monitoring for azole antifungals.
Purpose of the Study:
- To highlight the necessity of screening pediatric patients for central nervous system (CNS) aspergillosis.
- To advocate for a structured approach in evaluating CNS involvement in pediatric invasive aspergillosis.
Main Methods:
- This study reviews existing literature and clinical guidelines.
- It analyzes the implications of CNS aspergillosis on treatment decisions in pediatric populations.
Main Results:
- Current guidelines do not recommend screening for extra-pulmonary sites, including the CNS.
- Identifying CNS aspergillosis is critical for selecting appropriate antifungal agents and achieving target plasma concentrations.
Conclusions:
- A structured screening protocol for CNS aspergillosis in pediatric patients is essential.
- Adopting such an approach will improve patient outcomes by enabling timely and targeted antifungal therapy.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Sputum Studies II: Culture and Sensitivity
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
Pneumonia III: Complications and Assessment
Other Pulmonary Disorders
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

